A detailed history of Grove Bank & Trust transactions in Stryker Corp stock. As of the latest transaction made, Grove Bank & Trust holds 122 shares of SYK stock, worth $45,235. This represents 0.01% of its overall portfolio holdings.

Number of Shares
122
Previous 66 84.85%
Holding current value
$45,235
Previous $22,000 100.0%
% of portfolio
0.01%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$315.94 - $371.96 $17,692 - $20,829
56 Added 84.85%
122 $44,000
Q2 2024

Jul 24, 2024

SELL
$324.3 - $354.67 $3,567 - $3,901
-11 Reduced 14.29%
66 $22,000
Q2 2023

Jul 27, 2023

SELL
$271.49 - $305.09 $5,701 - $6,406
-21 Reduced 21.43%
77 $23,000
Q1 2023

May 10, 2023

BUY
$246.13 - $285.47 $3,938 - $4,567
16 Added 19.51%
98 $27,000
Q4 2022

Feb 03, 2023

BUY
$205.51 - $253.93 $16,851 - $20,822
82 New
82 $20,000
Q1 2018

May 07, 2018

SELL
$148.01 - $168.91 $19,981 - $22,802
-135 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$138.36 - $147.87 $18,678 - $19,962
135
135 $19,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.